Penumbra Inc

PEN

Penumbra Inc

PEN

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-04-02Shares Purchased (TTM):0Shares Sold (TTM):54,048

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:32,186,505Shares Outstanding:39,275,424Institutional Ownership Pct.:81.95%

Earnings Market Reaction:

Filing Date:2026-07-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	205	241	187	321	422	376	324	280	288	223	167	101
Available For Sale Securities Debt Securities Curr…	454	374	358	149	3	3	16	11	51	90	122	148
Accounts Receivable Net Current	190	183	190	183	176	168	168	176	201	192	202	207
Inventory Net	443	439	432	432	428	416	407	393	374	398	388	374
Prepaid Expense And Other Assets Current	52	38	50	55	38	37	37	31	29	31	36	39
Assets Current	1,344	1,275	1,217	1,142	1,065	1,000	951	892	944	935	915	868
Property Plant And Equipment Net	147	134	117	98	85	72	63	60	58	76	73	66
Operating Lease Right Of Use Asset	167	170	174	171	174	175	178	181	183	186	189	185
Finance Lease Right Of Use Asset	24	25	26	27	28	27	28	29	29	30	31	31
Intangible Assets Net Excluding Goodwill	6	6	6	6	7	6	7	7	7	68	71	73
Goodwill	167	167	167	167	167	166	166	166	166	166	166	166
Deferred Income Tax Assets Net	79	80	79	94	109	102	100	106	109	85	85	64
Other Assets Noncurrent	41	41	41	40	40	44	41	39	39	34	26	15
Assets	1,975	1,898	1,827	1,744	1,675	1,593	1,533	1,479	1,535	1,580	1,556	1,468
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	45	44	35	30	28	31	31	33	33	32	27	28
Accrued Liabilities Current	172	152	132	124	114	113	112	106	104	107	111	104
Operating Lease Liability Current	14	14	14	13	13	13	12	12	12	12	11	11
Finance Lease Liability Current	2	2	2	2	2	2	2	2	2	2	2	2
Liabilities Current	234	212	183	170	158	159	158	153	151	153	151	145
Operating Lease Liability Noncurrent	176	179	183	180	183	185	187	190	192	195	197	192
Finance Lease Liability Noncurrent	20	20	21	21	22	21	22	22	23	23	24	24
Other Liabilities Noncurrent	14	13	12	15	18	16	15	9	8	6	5	3
Liabilities	444	425	399	386	381	380	382	375	373	376	377	364
Stockholders Equity Inclu…
Preferred Stock Value	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,224	1,201	1,186	1,165	1,146	1,117	1,097	1,079	1,081	1,062	1,047	1,031
Accumulated Other Comprehensive Income Loss Net Of…	1	2	4	3	3	-3	-6	-1	-5	-5	-3	-7
Retained Earnings Accumulated Deficit	305	270	238	190	144	99	60	26	86	146	135	81
Stockholders Equity	1,531	1,474	1,428	1,359	1,294	1,213	1,151	1,104	1,161	1,204	1,179	1,104
Liabilities And Stockholders Equity	1,975	1,898	1,827	1,744	1,675	1,593	1,533	1,479	1,535	1,580	1,556	1,468
Allowance For Doubtful Accounts Receivable Current	-	-	2	-	-	-	6	-	-	-	3	-
Preferred Stock Par Or Stated Value Per Share	-	-	0.001	-	-	-	0.001	-	-	-	0.001	-
Preferred Stock Shares Authorized	-	-	5	-	-	-	5	-	-	-	5	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	-	-	0.001	-	-	-	0.001	-	-	-	0.001	-
Common Stock Shares Authorized	-	-	300	-	-	-	300	-	-	-	300	-
Common Stock Shares Issued	-	-	39	-	-	-	38	-	-	-	39	-
Shares Outstanding	-	-	39	-	-	-	38	-	-	-	39	-
Allowance For Doubtful Accounts Receivable	2	2	-	2	6	6	-	3	3	3	-	3

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.82%	-2.33%	-1.68%	-	-	-	-	-	-	-	-	-
2025	0.69%	-7.99%	-14.65%	16.55%	12.52%	9.62%	29.99%	40.54%	59.29%	-0.83%	-1.93%	-4.83%
2024	-9.78%	-14.30%	-15.03%	21.39%	12.66%	20.54%	15.88%	14.79%	24.80%	0.55%	0.44%	9.66%
2023	-	-	-	-15.72%	-17.03%	-31.12%	17.47%	30.42%	26.25%	-15.43%	-17.22%	-19.19%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.75	6.02	6.64	6.73	6.75	6.30	6.01	5.82	6.25	6.12	6.06	5.99
Quick Ratio	3.63	3.77	4.01	3.85	3.80	3.45	3.21	3.05	3.58	3.31	3.25	3.14
Working Capital	1.11B	1.06B	1.03B	971.92M	907.72M	841.08M	792.78M	738.57M	792.80M	782.22M	764.26M	723.40M
Leverage & Debt
Debt to Equity	0.29	0.29	0.28	0.28	0.29	0.31	0.33	0.34	0.32	0.31	0.32	0.33
Interest Coverage TTM	-	-	-	-	-	-	-	-	-18.88	39.57	29.23	15.40
Debt Ratio	0.22	0.22	0.22	0.22	0.23	0.24	0.25	0.25	0.24	0.24	0.24	0.25
Efficiency & Turnover
Asset Turnover TTM	0.82	0.83	0.84	0.83	0.80	0.78	0.77	0.79	0.76	0.74	0.72	0.71
Days Sales Outstanding TTM	44.38	44.08	46.51	49.19	53.66	52.98	56.44	60.01	65.97	66.51	69.85	72.56
Receivables Turnover TTM	8.22	8.28	7.85	7.42	6.80	6.89	6.47	6.08	5.53	5.49	5.23	5.03
Per Share Metrics
Diluted EPS TTM	4.06	4.33	4.52	4.17	3.76	1.08	0.36	0.88	0.37	2.37	2.32	1.04
Free Cash Flow Per Share TTM	5.49	5.42	4.49	3.91	4.16	3.90	3.81	3.48	2.85	2.72	2.14	1.23
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	67.84%	67.38%	67.14%	66.80%	66.47%	63.68%	63.20%	62.84%	62.51%	65.04%	64.49%	63.72%
Operating Profit Margin TTM	12.45%	12.87%	13.48%	12.95%	12.45%	3.03%	0.78%	0.13%	-1.87%	7.09%	6.95%	4.36%
Net Profit Margin TTM	10.67%	11.76%	12.66%	12.30%	11.54%	3.41%	1.17%	2.97%	1.26%	8.52%	8.59%	4.08%
Growth Metrics
Net Revenue Growth (1Y)	17.55%	17.27%	17.50%	14.61%	12.92%	13.17%	12.86%	16.96%	20.89%	23.87%	24.95%	19.90%
Net Income Growth (1Y)	8.72%	305.01%	1,168.11%	374.79%	937.68%	-54.78%	-84.59%	-14.94%	-51.13%	1,341.04%	-4,643.16%	-241.66%
EPS Growth (1Y)	7.29%	297.66%	1,158.83%	369.11%	936.57%	-54.60%	-84.69%	-15.26%	-51.73%	1,321.28%	-4,576.99%	-239.65%
Valuation Metrics
P/E TTM	77.38	75.40	68.10	60.35	67.47	244.17	654.78	217.17	490.49	92.52	106.20	229.10
P/B TTM	8.12	8.75	8.48	7.29	7.70	8.50	7.97	6.79	6.01	7.18	8.19	8.43
P/S TTM	8.26	8.87	8.62	7.42	7.79	8.32	7.68	6.45	6.16	7.89	9.13	9.35
Market Cap	12.43B	12.90B	12.10B	9.90B	9.97B	10.31B	9.17B	7.50B	6.98B	8.64B	9.66B	9.30B
Enterprise Value	12.24B	12.68B	11.94B	9.60B	9.57B	9.96B	8.87B	7.25B	6.72B	8.44B	9.52B	9.23B
Calculated Values
Free Cash Flow TTM	215.91M	212.73M	174.93M	152.62M	161.62M	150.33M	147.30M	134.18M	110.67M	105.36M	82.12M	47.28M
Net Debt	-183.26M	-218.68M	-163.79M	-297.38M	-397.59M	-352.56M	-300.30M	-255.82M	-263.51M	-197.74M	-141.58M	-74.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-04-02Sale

Owner: Grewal, Harpreet

Title: -

Shares: 100

Price/Share: $328.22

Value: $32,822.00

Shares Owned: 8,719

Relationship: Director

Ownership: Direct

2026-03-02Sale

Owner: Yuen, Maggie

Title: Chief Financial Officer

Shares: 2,432

Price/Share: $342.30

Value: $832,473.60

Shares Owned: 18,353

Relationship: Officer

Ownership: Direct

2026-01-06Sale

Owner: Grewal, Harpreet

Title: -

Shares: 186

Price/Share: $312.64

Value: $58,151.04

Shares Owned: 8,230

Relationship: Director

Ownership: Direct

2026-01-02Sale

Owner: Wilder, Thomas

Title: -

Shares: 186

Price/Share: $310.72

Value: $57,793.92

Shares Owned: -

Relationship: Director

Ownership: Direct

2025-12-11Sale

Owner: Bose, Arani

Title: -

Shares: 15,000

Price/Share: $308.72

Value: $4,630,800.00

Shares Owned: 258,462

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-02	Grewal, Harpreet	Director	-	Direct	Sale	100	328.22	$32,822.00	8,719	4
2026-03-02	Yuen, Maggie	Officer	Chief Financial Officer	Direct	Sale	2,432	342.30	$832,473.60	18,353	4
2026-01-06	Grewal, Harpreet	Director	-	Direct	Sale	186	312.64	$58,151.04	8,230	4
2026-01-02	Wilder, Thomas	Director	-	Direct	Sale	186	310.72	$57,793.92	0	4
2025-12-11	Bose, Arani	Director	-	Indirect	Sale	15,000	308.72	$4,630,800.00	258,462	4
2025-12-05	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	300	300.13	$90,039.00	63,836	4
2025-12-02	Grewal, Harpreet	Director	-	Direct	Sale	100	292.98	$29,298.00	8,416	4
2025-12-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	295.29	$177,174.00	64,136	4
2025-11-25	Bose, Arani	Director	-	Indirect	Sale	7,500	300.19	$2,251,425.00	275,261	4
2025-11-25	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	1,800	300.06	$540,108.00	64,736	4
2025-11-21	Bose, Arani	Director	-	Indirect	Sale	7,500	290.82	$2,181,150.00	282,761	4
2025-11-10	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	266.75	$160,050.00	63,657	4
2025-11-04	Grewal, Harpreet	Director	-	Direct	Sale	186	227.58	$42,329.88	8,516	4
2025-10-02	Grewal, Harpreet	Director	-	Direct	Sale	186	248.61	$46,241.46	8,702	4
2025-10-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	249.84	$149,904.00	64,257	4
2025-10-01	Wilder, Thomas	Director	-	Direct	Sale	186	253.93	$47,230.98	186	4
2025-09-03	Elsesser, Adam	Director,Officer	CEO	Direct	Sale	15,800	269.64	$4,260,312.00	182,460	4
2025-09-02	Grewal, Harpreet	Director	-	Direct	Sale	186	272.19	$50,627.34	8,888	4
2025-09-02	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	271.19	$162,714.00	64,857	4
2025-08-20	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	15,900	254.66	$4,049,094.00	170,280	4
2025-08-13	Yuen, Maggie	Officer	Chief Financial Officer	Direct	Sale	2,000	250.00	$500,000.00	12,943	4
2025-08-13	Bose, Arani	Director	-	Direct	Sale	12,000	250.86	$3,010,320.00	558	4
2025-08-12	Wilder, Thomas	Director	-	Direct	Sale	372	240.16	$89,339.52	372	4
2025-08-11	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	239.19	$143,514.00	65,457	4
2025-08-06	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,030	238.74	$3,827,002.20	158,204	4
2025-07-23	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,150	233.09	$3,764,403.50	146,258	4
2025-07-09	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	15,985	244.66	$3,910,890.10	134,432	4
2025-07-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	251.89	$151,134.00	66,057	4
2025-06-25	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	15,890	254.41	$4,042,574.90	122,441	4
2025-06-16	O'Rourke, Bridget	Director	-	Direct	Sale	50	259.78	$12,989.00	5,373	4
2025-06-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	15,910	253.50	$4,033,185.00	110,355	4
2025-06-02	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	261.28	$156,768.00	64,714	4
2025-05-28	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,300	268.48	$4,376,224.00	98,289	4
2025-05-15	O'Rourke, Bridget	Director	-	Direct	Sale	100	286.15	$28,615.00	5,423	4
2025-05-14	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,600	296.28	$4,918,248.00	86,613	4
2025-05-12	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	900	296.91	$267,219.00	65,314	4
2025-05-07	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,650	290.94	$4,844,151.00	75,237	4
2025-05-02	Yuen, Maggie	Officer	Chief Financial Officer	Direct	Sale	2,000	299.01	$598,020.00	13,957	4
2025-04-25	Bose, Arani	Director	-	Direct	Sale	12,000	299.39	$3,592,680.00	302,819	4
2025-04-24	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	300.01	$180,006.00	66,159	4
2025-04-16	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,560	274.69	$4,548,866.40	63,911	4
2025-04-15	O'Rourke, Bridget	Director	-	Direct	Sale	50	271.21	$13,560.50	5,523	4
2025-04-02	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,565	272.32	$4,510,980.80	52,495	4
2025-04-02	Wilder, Thomas	Director	-	Indirect	Sale	360	266.93	$96,094.80	4,692	4
2025-04-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	267.89	$160,734.00	66,353	4
2025-04-01	Grewal, Harpreet	Director	-	Direct	Sale	200	267.17	$53,434.00	9,074	4
2025-03-31	Wilder, Thomas	Director	-	Indirect	Sale	360	264.58	$95,248.80	4,533	4
2025-03-25	Bose, Arani	Director	-	Direct	Sale	12,000	284.79	$3,417,480.00	314,819	4
2025-03-19	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	16,600	275.03	$4,565,498.00	27,752	4
2025-03-05	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	61,600	283.72	$17,477,152.00	16,376	4
2025-03-04	Shiu, Lambert	Officer	Chief Accounting Officer	Direct	Sale	501	282.88	$141,722.88	32,969	4
2025-03-03	O'Rourke, Bridget	Director	-	Direct	Sale	50	285.48	$14,274.00	5,573	4
2025-03-03	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	287.25	$172,350.00	66,539	4
2025-03-03	Yuen, Maggie	Officer	Chief Financial Officer	Direct	Sale	2,000	285.80	$571,600.00	15,243	4
2025-03-03	Bose, Arani	Director	-	Direct	Sale	12,000	287.36	$3,448,320.00	326,819	4
2025-01-03	Grewal, Harpreet	Director	-	Direct	Sale	167	241.28	$40,293.76	8,530	4
2025-01-02	Kassing, Don W.	Director	-	Direct	Sale	170	238.84	$40,602.80	665	4
2024-12-20	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	242.90	$3,643,500.00	837,582	4
2024-12-02	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	243.88	$146,328.00	63,444	4
2024-12-02	Shiu, Lambert	Officer	Chief Accounting Officer	Direct	Sale	654	243.01	$158,928.54	20,028	4
2024-11-20	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	237.22	$3,558,300.00	852,582	4
2024-11-18	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	238.98	$143,388.00	64,044	4
2024-10-21	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	204.71	$3,070,650.00	867,582	4
2024-10-02	Grewal, Harpreet	Director	-	Direct	Sale	166	190.83	$31,677.78	8,697	4
2024-10-01	Kassing, Don W.	Director	-	Direct	Sale	170	193.93	$32,968.10	835	4
2024-10-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	191.07	$114,642.00	60,488	4
2024-09-20	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	197.63	$2,964,450.00	882,582	4
2024-09-04	Grewal, Harpreet	Director	-	Direct	Sale	782	204.11	$159,614.02	8,863	4
2024-09-03	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	206.04	$123,624.00	61,088	4
2024-08-23	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	28,380	203.94	$5,787,817.20	897,582	4
2024-08-13	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	176.52	$105,912.00	61,688	4
2024-07-17	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	201.91	$3,028,650.00	927,582	4
2024-07-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	179.42	$107,652.00	62,288	4
2024-07-01	Kassing, Don W.	Director	-	Direct	Sale	170	179.99	$30,598.30	1,005	4
2024-06-03	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	189.59	$113,754.00	62,888	4
2024-05-20	Elsesser, Adam	Director,Officer	CEO and President	Indirect	Sale	15,000	201.90	$3,028,500.00	942,582	4
2024-05-13	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	209.33	$125,598.00	63,488	4
2024-04-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	219.96	$131,976.00	64,281	4
2024-04-01	Kassing, Don W.	Director	-	Direct	Sale	170	223.18	$37,940.60	1,175	4
2024-03-04	Bose, Arani	Director	-	Direct	Sale	7,500	250.20	$1,876,500.00	164,294	4
2024-03-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	236.72	$142,032.00	62,997	4
2024-03-01	Kassing, Don W.	Director	-	Direct	Sale	778	234.72	$182,612.16	1,345	4
2024-01-03	Grewal, Harpreet	Director	-	Direct	Sale	170	240.82	$40,939.40	8,980	4
2024-01-02	Sarna, Surbhi	Director	-	Direct	Sale	85	247.68	$21,052.80	2,295	4
2023-12-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	225.41	$135,246.00	62,251	4
2023-11-30	O'Rourke, Bridget	Director	-	Direct	Sale	150	226.41	$33,961.50	4,214	4
2023-11-14	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	213.82	$128,292.00	63,037	4
2023-10-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,670	220.96	$2,136,683.20	0	4
2023-10-02	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	238.59	$143,154.00	63,637	4
2023-10-02	Grewal, Harpreet	Director	-	Direct	Sale	170	240.99	$40,968.30	9,150	4
2023-10-02	Sarna, Surbhi	Director	-	Direct	Sale	85	240.99	$20,484.15	2,380	4
2023-09-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,666	298.40	$2,884,334.40	0	4
2023-09-08	Kassing, Don W.	Director	-	Direct	Sale	444	288.66	$128,165.04	1,458	4
2023-09-01	Sarna, Surbhi	Director	-	Direct	Sale	85	266.62	$22,662.70	2,465	4
2023-09-01	O'Rourke, Bridget	Director	-	Direct	Sale	100	266.62	$26,662.00	4,364	4
2023-09-01	Grewal, Harpreet	Director	-	Direct	Sale	340	266.62	$90,650.80	9,320	4
2023-09-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	265.38	$159,228.00	64,237	4
2023-08-14	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	249.14	$149,484.00	64,837	4
2023-08-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,666	247.41	$2,391,465.06	0	4
2023-08-08	Kassing, Don W.	Director	-	Direct	Sale	323	251.00	$81,073.00	1,902	4
2023-08-07	Wilder, Thomas	Director	-	Direct	Sale	340	253.48	$86,183.20	340	4
2023-07-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,666	324.24	$3,134,103.84	0	4
2023-07-03	Sarna, Surbhi	Director	-	Direct	Sale	27	341.45	$9,219.15	2,550	4
2023-07-03	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	900	340.63	$306,567.00	65,437	4
2023-06-12	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,666	324.26	$3,134,297.16	0	4
2023-06-01	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	900	310.20	$279,180.00	66,337	4
2023-05-12	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	1,500	320.61	$480,915.00	68,925	4
2023-05-11	Elsesser, Adam	Director,Officer	CEO and President	Direct	Sale	9,666	319.05	$3,083,937.30	0	4
2023-05-01	Bose, Arani	Director	-	Direct	Sale	5,000	286.22	$1,431,100.00	182,629	4
2023-04-03	Bose, Arani	Director	-	Direct	Sale	5,000	275.93	$1,379,650.00	431,342	4
2023-04-03	Roberts, Johanna	Officer	EVP, Gen. Counsel & Secretary	Direct	Sale	600	277.69	$166,614.00	69,960	4
2023-04-03	Sarna, Surbhi	Director	-	Direct	Sale	28	276.37	$7,738.36	2,577	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

81.95%

Inst. Shares: 32,186,505

Shares Outstanding: 39,275,424

2025-12-31

87.57%

Inst. Shares: 34,082,407

Shares Outstanding: 38,918,493

2025-09-30

85.64%

Inst. Shares: 33,465,618

Shares Outstanding: 39,078,378

2025-06-30

85.36%

Inst. Shares: 33,148,222

Shares Outstanding: 38,834,917

2025-03-31

81.72%

Inst. Shares: 31,512,999

Shares Outstanding: 38,562,191

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	32,186,505	39,275,424	81.95%
2025-12-31	34,082,407	38,918,493	87.57%
2025-09-30	33,465,618	39,078,378	85.64%
2025-06-30	33,148,222	38,834,917	85.36%
2025-03-31	31,512,999	38,562,191	81.72%
2024-12-31	31,869,126	38,633,744	82.49%
2024-09-30	31,409,809	38,610,805	81.35%
2024-06-30	31,572,762	38,793,341	81.39%
2024-03-31	29,782,800	38,717,334	76.92%
2023-12-31	30,717,571	38,401,171	79.99%
2023-09-30	30,206,820	38,462,463	78.54%
2023-06-30	30,793,291	38,320,999	80.36%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Penumbra Inc (PEN) — SEC Financial Statements & Analysis

Penumbra Inc (PEN) is a surgical & medical instruments & apparatus company, incorporated in DE. Penumbra Inc trades on NYSE as: PEN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Penumbra Inc reported a 17.55% year-over-year revenue growth, a Gross Profit Margin of 67.84% (TTM), a Debt-to-Equity ratio of 0.29x, a Price-to-Sales (P/S) ratio of 8.26x (TTM), a Price-to-Book (P/B) ratio of 8.12x (TTM), at a market cap of $12.43B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 17.55%
Gross Profit Margin TTM: 67.84%
Debt To Equity: 0.29x
P/S TTM: 8.26x
P/B TTM: 8.12x
Market Cap: $12.43B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Penumbra Inc in?

Penumbra Inc (PEN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is PEN's market cap?

Penumbra Inc (PEN) has a market capitalization of $12.43B as of 2026-06-30.

What is PEN's P/E ratio?

Penumbra Inc (PEN)'s trailing twelve month P/E ratio is 77.38x as of 2026-06-30.

What exchange does PEN trade on?

Penumbra Inc (PEN) trades on the NYSE.

Where is Penumbra Inc incorporated?

Penumbra Inc is incorporated in DE.

Penumbra Inc

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Penumbra Inc (PEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

Penumbra Inc (PEN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.